Crossmark

Use of the 10-meter timed walk for monitoring long-term gait progression in human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis: a 10-year analysis from the Japanese HAM-net registry

Crossref DOI link: https://doi.org/10.1186/s13023-026-04399-y

Published Online: 2026-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marubayashi, Fuyuhiko https://orcid.org/0009-0008-7562-3719
Mogi, Yasuyuki

Sato, Tomoo https://orcid.org/0000-0001-8439-3128
Yagishita, Naoko https://orcid.org/0000-0001-9810-5019
Ishii, Manabu https://orcid.org/0009-0008-3406-2150
Hida, Hideaki

Tanabe, Kenichiro https://orcid.org/0000-0001-6271-2490
Yamano, Yoshihisa https://orcid.org/0000-0001-7527-0345
License Information

Text and Data Mining valid from 2026-05-25

Version of Record valid from 2026-07-22
More Information

Article History

Received: 3 February 2025

Accepted: 7 May 2026

First Online: 25 May 2026

Declarations

Ethics approval and consent to participate: This study was approved by the Human Tissue Research Ethics Review Committee of Tanabe Pharma Corporation.

Consent for publication: Not applicable.

Competing interests: FM and YM are employees of Tanabe Pharma America, Inc. MI and HH are employees of Tanabe Pharma Corporation. YY received consulting fees from Tanabe Pharma Corporation.

Document is current

Any future updates will be listed below